Biopharmaceuticals

• 12/29/2024

  Psyence Biomedical Reborn: Nasdaq Compliance Achieved

• 12/29/2024

  Reviving a Giant: Can Self-Organization Save Bayer?

• 12/28/2024

  Pharma Software Wars: Salesforce Challenges Veeva’s Dominance

• 12/28/2024

  Tirzepatide Access in Jeopardy: Patients Face Uncertain Future

• 12/26/2024

  Cingulate Inc. Lands $5M Funding to Fuel Drug Pipeline Growth

• 12/25/2024

  Vertex Pharmaceuticals: New Forecast and Pipeline Updates

• 12/24/2024

  Eli Lilly’s Unstoppable Rise: A Pharmaceutical Powerhouse

• 12/23/2024

  Merck Bets Big on Obesity Market with $2 Billion Weight Loss Pill Deal

• 12/23/2024

  FDA Greenlights Revolutionary Sleep Apnea Treatment, Offering New Hope to Millions

• 12/23/2024

  Tirzepatide Shortage Ends: What It Means for Patients and Pharmacies